Rvl Pharmaceuticals Plc's

• RVLP's Stock Performance relative to its Competitors

Abbvie Inc Share Performance +11.86% This Year

Abbvie Inc Profile AbbVie Inc operates primarily as a global biopharmaceutical company, focusing on the research, development, manufacturing, and commercialization of advanced therapies and medications in critical areas such as immunology, oncology, neuroscience, and virology. The company aims to improve patient outcomes and address unmet medical needs by leveraging its scientific expertise and capabilities while providing value to stakeholders in the healthcare industry. More about Abbvie Inc 's Market Share

Biodexa Pharmaceuticals Plc Share Performance -95.71% One Year

Biodexa Pharmaceuticals Plc Profile Biodexa Pharmaceuticals Plc operates as a biopharmaceutical company that focuses on the research, development, and commercialization of innovative medical solutions. Their business model revolves around leveraging scientific expertise to bring new medicines to market and meet the healthcare needs of patients worldwide. More about Biodexa Pharmaceuticals Plc's Market Share

Evolus Inc Share Performance -12.71% Over The Past 5 Days

Evolus Inc Profile Evolus Inc is a pharmaceutical company that operates in the field of aesthetics, with a primary focus on developing and commercializing minimally invasive treatments for patients. Their business model revolves around researching and developing innovative neurotoxin products to address various facial aesthetic concerns. The company aims to bring their products to market through strategic partnerships with healthcare professionals and providers, ensuring widespread accessibility and utilization. More about Evolus Inc 's Market Share

Revance Therapeutics Inc Share Performance -37.18% This Quarter

Revance Therapeutics Inc Profile Revance Therapeutics Inc is a biotechnology company that specializes in developing innovative treatments for medical aesthetic and therapeutic applications. Their business model revolves around researching and developing novel neuromodulator products primarily for the treatment of various aesthetic and therapeutic conditions. The company aims to license or commercialize their products and technologies to generate revenue and advance patient care in collaboration with partners. More about Revance Therapeutics Inc 's Market Share

Lifecore Biomedical Inc Share Performance -45.48% One Year

Lifecore Biomedical Inc Profile Lifecore Biomedical is a contract development and manufacturing organization (CDMO) specializing in the development and aseptic manufacturing of sterile injectable pharmaceuticals. More about Lifecore Biomedical Inc 's Market Share

Sources: Rvl Pharmaceuticals Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Wednesday, September 9, 2026 10:37 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Rvl Pharmaceuticals Plc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.